Potassium Channels
-
ICA-110381
Catalog No. A15503 -
NS-1643
Catalog No. A15929 -
NS1619
Catalog No. A15975 -
K+ Channel inhibitor
Catalog No. A16182 -
Cesium chloride
Catalog No. A15341 Potassium channel blockerCesium chloride是钾通道阻滞剂。抑制起搏器电流(If)和超极化激活的阳离子电流(Ih)。通过灭活GSK-3β来防止血清和钾缺乏的小脑颗粒神经元中caspase-3的激活和神经元凋亡。 了解更多 -
-
最新产品
SKA-31
Catalog No. A17117 -
-
4-Aminopyridine
Catalog No. A17490 Potassium channel blockerDalfampridine is a potassium channel blocker used to help multiple sclerosis patients walk. 了解更多 -
ML418
Catalog No. A18426 Kir7.1 potassium channels blockerML418 is a selective, sub-micromolar pore blocker of Kir7.1 potassium channels. The inward rectifier potassium (Kir) channel Kir7.1 (KCNJ13) is a key regulator of melanocortin signaling in the brain, electrolyte homeostasis in the eye, and uterine muscle contractility during pregnancy. 了解更多 -
JNJ 303
Catalog No. A20952 -
RPR-260243
Catalog No. A20977 HERG activatorRPR-260243 is a novel activator of HERG; modifies HERG currents inhibited by dofetilide (IC50 = 58 nM); little effect on HERG current amplitude and no significant effects on steady-state activation parameters or on channel inactivation processes. 了解更多 -
MK-7145
Catalog No. A21030 -
TAK-438 (vonoprazan)
Catalog No. A11239 -
Orphenadrine citrate
Catalog No. A11712 -
NS 309
Catalog No. A11934 -
Glimepiride
Catalog No. A10430 Kir6.2/SUR 抑制剂Glimepiride是一种强效Kir6.2/SUR抑制剂,SUR1、SUR2A和SURB的IC50分别为3.0 nM、5.4 nM和7.3 nM,用于治疗2型糖尿病化合物。 了解更多 -
Retigabine (Ezogabine)
Catalog No. A11922 Retigabine是一种新型的抗痉挛剂,在大范围的惊厥模型具有活性。其发挥活性的机制主要是开放神经元的KCNQ2-5电压门控钾离子通道。 了解更多 -
Hydralazine hydrochloride
Catalog No. A10455 Hydralazine hydrochloride是肼屈嗪的盐酸盐(安普索林),是一种直接作用的平滑肌松弛剂,IC50为1.9 mM。 了解更多 -
Minoxidil (U-10858)
Catalog No. A10593 Minoxidil (U-10858)是一种选择性的ATP依赖性K+(Kir6)通道激活剂。 了解更多 -
Nateglinide (Starlix)
Catalog No. A10629 Nateglinide(Starlix)是一种胰岛素促分泌剂,可通过刺激胰腺分泌胰岛素来降低血糖水平。 了解更多 -
Mitiglinide calcium
Catalog No. A11884 -
PAP-1 (5-(4-Phenoxybutoxy)psoralen)
Catalog No. A11521 Kv1.3 blockerPAP-1 (5-(4-Phenoxybutoxy)psoralen) 是一种有效的,选择性的,口服活性的?Kv1.3?阻滞剂 (EC50=2 nM)。PAP-1 以使用依赖性方式阻止 Kv1.3,并通过优先绑定到通道的 C 型灭活状态来起作用。 了解更多 -
E-4031 dihydrochloride
Catalog No. A12857 K+ channel blocker?E-4031 dihydrochloride是KV11.1(hERG)通道的选择性阻滞剂;禁止快速延迟整流器K+电流(IKr)。 了解更多 -
Nicorandil
Catalog No. A10641 -
Repaglinide
Catalog No. A10783 Potassium Channel 抑制剂Repaglinide是一种有效的短效胰岛素促分泌剂,可通过关闭胰岛β细胞质膜中的ATP敏感性钾(KATP)通道发挥作用。 了解更多 -
GW 542573X
Catalog No. A13944 -
Retigabine dihydrochloride
Catalog No. A15222 KCNQ channel openerRetigabine dihydrochloride是具有抗惊厥活性的Kv7.2-7.5(KCNQ2-5)神经元钾通道开放剂。 了解更多 -
Vernakalant HCl
Catalog No. A15275 Ion channel blockerVernakalant hydrochloride是一种研究性混合离子通道阻滞剂,可以以2至5 mg/kg的剂量终止人的急性心房纤颤(AF),并且与现有药物相比,对房颤的选择性更高。在抗心律不齐的治疗中。 了解更多